Ann L. MacDougall

This profile gathers the share dealings of Ann L. MacDougall in Opiant Pharmaceuticals, Inc., where the filings describe the role as board member. Over a trading history stretching from 4 June 2018 to 2 March 2023, the count stands at 41 filings.

Market trades split into 28 purchases (€167k) and 3 sales (€135k). On balance, insiders were net buyers of €33k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 5 option exercises.

A typical purchase (the median) is worth €2,148. 27 out of 27 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 3 March 2023 came the latest disclosure, a transaction for €37k in Opiant Pharmaceuticals, Inc. The last purchase on record was published on 16 May 2022, which is 1,622 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.